Ethnopharmacological, Phytochemistry, and Antiviral Activity of Plants Belonging to Genus Sida - A Systematic Review

Authors

  • Zunita Puspita Sari Master Programme of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
  • Achmad Fuad Hafid Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
  • Zainal Amiruddin Zakaria Borneo Research on Algesia, inflammation and Neurodegeneration Group, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Sabah, Malaysia
  • Tutik Sri Wahyuni Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia

DOI:

https://doi.org/10.48048/tis.2025.9289

Keywords:

Viral infections, Medicine, Genus sida, Natural products, Medicine plant

Abstract

Viral infections are significant global health concerns, particularly in regions with limited healthcare infrastructure. The leading causes of viral-related mortality worldwide include influenza, COVID-19, Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS), and lower respiratory infections, such as pneumonia. Current antiviral therapies, such as protease and reverse transcriptase inhibitors, are effective but limited by high costs, side effects and drug resistance. This review aimed to provide an overview of the current landscape of viral infections, their impact, and available treatments.  This review explores the antiviral potential of natural products, focusing on the genus Sida. A systematic literature search using database like PubMed, Science direct, Google Scholar and Wiley Online Library identified on Sida traditional uses, chemical composition and antiviral properties. This review outlined the the overview of Sida Genus  as a promising source for new antiviral coumpounds due to its bioactive properties that may inhibit viral infection.

HIGHLIGHTS

  • Bioactive Metabolites: Identification of antiviral compounds of several Sida species, including quindoline, cryptolepinone, vasicine, and kaempferol derivatives.
  • Antiviral Mechanisms: Evidence suggests these compounds can disrupt viral replication and infectivity, supporting their potential as antiviral agents.
  • Ethnopharmacological: Supports traditional uses of Sida for ailments like fever and skin infections, reinforcing its therapeutic relevance.
  • Drug Development Potential: Sida species offer a promising, cost-effective source for new antiviral drug candidates with potentially fewer side effects

GRAPHICAL ABSTRACT

Downloads

Download data is not yet available.

References

N Nathanson. The human toll of viral diseases: Past plagues and pending pandemics. Elsevier Science, Amsterdam, Netherlands, 2016.

C Bochen, S Gretchen, A Ho, M Jessica and D Fat. WHO methods and data sources for country-level causes of death. World Health Organisation, Geneva, Switzerland, 2020.

M Naghavi, T Mestrovic, A Gray, AG Hayoon, LR Swetschinski, GR Aguilar, ND Weaver, KS Ikuta, E Chung, EE Wool, C Han, DT Araki, SB Albertson, R Bender, G Bertolacci, AJ Browne, BS Cooper, MW Cunningham, C Dolecek, … CJL Murray. Global burden associated with 85 pathogens in 2019: A systematic analysis for the global burden of disease study 2019. The Lancet Infectious Diseases 2024; 24(8), 868-895.

RE Baker, AS Mahmud, IF Miller, M Rajeev, F Rasambainarivo, BL Rice, S Takahashi, AJ Tatem, CE Wagner, L Wang, A Wesolowski and CJE Metcalf. Infectious disease in an era of global change. Nature Reviews Microbiology 2022; 20(4), 193-205.

N Mboi, R Syailendrawati, SM Ostroff, IRF Elyazar, SD Glenn, T Rachmawati, WP Nugraheni, PB Ali, L Trisnantoro, QES Adnani, RI Agustiya, AD Laksono, B Aji, L Amalia, A Ansariadi, E Antriyandarti, I Ardani, R Ariningrum, NK Aryastami, …, AH Mokdad. The state of health in Indonesia’s provinces, 1990 - 2019: A systematic analysis for the global burden of disease study 2019. The Lancet Global Health 2022; 10(11), E1632-E1645.

WD Jong, M Rusli, S Bhoelan, FA Rantam, PA Noeryoto, U Hadi, ECMV Gorp and M Goeijenbier. Endemic and emerging acute virus infections in Indonesia: An overview of the past decade and implications for the future. Critical Reviews in Microbiology 2018; 44(4), 487-503.

D. R., Tompa, Immanuel, A., Srikanth, S., & Kadhirvel, S. (2021). Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs. International Journal of Biological Macromolecules, 172, 524–541.

G Pantaleo, B Correia, C Fenwick,VS Joo and L Perez. Antibodies to combat viral infections: Development strategies and progress. Nature Reviews Drug Discovery 2022; 21(9), 676-696.

S Kausar, F Said Khan, M Ishaq Mujeeb Ur Rehman, M Akram, M Riaz, G Rasool, AH Khan, I Saleem, S Shamim and A Malik. A review: Mechanism of action of antiviral drugs. International Journal of Immunopathology and Pharmacology 2021; 35, 1-12.

BC Goncalves, MG Lopes Barbosa, APS Olak, NB Terezo, L Nishi, MA Watanabe, P Marinello, DZ Rechenchoski, SPD Rocha and LC Fraccin-Galhardi. Antiviral therapies: Advances and perspectives. Fundamental and Clinical Pharmacology 2021; 35(2), 305-320.

SL Bermingham, R Hughes, SL Bermingham, R Hughes, E Fenu, LM Sawyer, E Boxall, PT Kennedy, G Dusheiko, G Hill-Cawthorne and H Thomas. Cost-effectiveness analysis of alternative antiviral strategies for the treatment of HBeAg-Positive and HBeAg-negative chronic hepatitis B in the United Kingdom. Value in Health 2015; 18(6), 800-809.

M Okusa. Antivirals for pandemic influenza: Guidance on developing a distribution and dispensing program. National Academy of Sciences, Nidwalden, Germany, 2008.

TS Wahyuni, AA Permatasari, T Wdiandani, A Fuad, A Widyawaruyanti, C Aoki-Utsubo and H Hotta. Antiviral activities of curcuma genus against hepatitis C virus. Natural Product Communications 2018; 13(12), 1579-1582.

TS Wahyuni, L Tumewu, AA Permanasari, E Apriani, M Adianti, A Rahman, A Widyawaruyanti, MI Lusida, A Fuad, Soetjipto, Nasronudin, H Fuchino, N Kawahara, I Shoji, L Deng, C Aoki and H Hotta. Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus. Virology Journal 2013; 10, 259.

TS Wahyuni, AA Permanasari, A Widyawaruyanti, H Hotta, C Aoki-Utsubo and AF Hafid. Antiviral activity of indonesian medicinal plants against hepatitis B virus. Pharmacognosy Journal 2020; 12(5), 1108-1114.

HD Marhaeny, A Widyawaruyanti, T Widiandani, AF Hafid and TS Wahyuni. Phyllanthin and hypophyllanthin, the isolated compounds of Phyllanthus niruri inhibit protein receptor of corona virus (COVID-19) through in silico approach. Journal of Basic and Clinical Physiology and Pharmacology 2021; 32(4), 809-815.

FC Rodrigues and AFMD Oliveira. The genus Sida L. (Malvaceae): An update of its ethnomedicinal use, pharmacology and phytochemistry. South African Journal of Botany 2020; 132, 432-462.

VV Sivarajan and AK Pradeep. Taxonomy of the sida rhombifolia ( malvaceae ) complex in india. The Botanical Research Institute of Texas, Texas, 1994.

DM Benjumea, IC Gomez-Betancur, J Vasquez, F Alzate, A Garcia-Silva and JA Fontenla. Neuropharmacological effects of the ethanolic extract of Sida acuta. Revista Brasileira de Farmacognosia 2016; 26(2), 209-215.

MAM Momin, SF Bellah, SMR Rahman, AA Rahman, GMM Murshid and TB Emran. Phytopharmacological evaluation of ethanol extract of Sida cordifolia L. roots. Asian Pacific Journal of Tropical Biomedicine 2014; 4(1), 18-24.

S Venkatesh, YS Reddy, B Suresh, BM Reddy and M Ramesh. Antinociceptive and anti-inflammatory activity of Sida rhomboidea leaves. Journal of Ethnopharmacology 1999; 67(2), 229-232.

UM Femoe, JBK Fassi, HB Jatsa, YL Tchoffo, DCA Nna, BC Kamdoum, SCN Wouamba, BT Tchegnitegni, Bonaventure T Ngadjui, N Sewald, BN Lenta, LT Tchuente, T Dimo. In vitro assessment of the cercaricidal activity of sida acuta burm . F . and sida rhombifolia Linn . (Malvaceae) hydroethanolic extracts, cytotoxicity, and phytochemical studies. 2022; 2022(1), 7281144.

D Sharma, R Mishra and MS Saluja. A brief overview of the ethnomedical, pharmacological, and phytochemical uses of Sida spinosa. International Journal of Medical, Pharmacy and Drug Research 2023; 7(5), 15-19.

AH Karomah, M Rafi, DA Septaningsih, A Ilmiawati, UD Syafitri, NS Aminah, M Insanu and A rohman. UHPLC-Q-Orbitrap HRMS-based untargeted metabolomics of sida rhombifolia leaves and stem extracts. HAYATI Journal of Biosciences 2023; 30(4), 770-778.

DM Ferro, S Mazzutti, L Vitali, CM Oliveira Muller and SRS Ferreira. Integrated extraction approach to increase the recovery of antioxidant compounds from Sida rhombifolia leaves. Journal of Supercritical Fluids 2019; 149, 10-19.

D Padmanabhan, P Natarajan and S Palanisamy. Integrated metabolite and transcriptome profiling-mediated gene mining of sida cordifolia reveals medicinally important genes. Genes 2022; 13(10), 1909.

RK Sutradhar, AKMM Rahman and MU Ahmad. Iranian chemical society three new flavonol C-glycosides from sida cordifolia linn. Journal of the Iraanian chemical Society 2007; 4(2), 175-181.

N Srinivasan and R Murali. An overview of the traditional importance, phytochemistry, and pharmacological properties of Sida acuta Burm.f. Annals of Phytomedicine: An International Journal 2022; 11(2), 245-254.

HSD Rosa, VBD Camargo, G Camargo, CV Garcia, AM Fuentefria and ASL Mendez. Ecdysteroids in sida tuberculata R.E. fries (Malvaceae): Chemical composition by LC-ESI-MS and selective anti-Candida krusei activity. Food Chemistry 2015; 182,193-199.

M Banni and M Jayaraj. Identification of bioactive compounds of leaf extracts of sida cordata (Burm.f.) borss.waalk. by GC/MS analysis. Applied Biochemistry and Biotechnology 2023; 195(1), 556-572.

S Uysal, R Gevrenova, KI Sinan, AU Bayarslan, YC Altunoglu, D Zheleva-Dimitrova, G Ak, MC Baloglu, OK Etienne, D lobine, MF Mohomoodally and G Zengin. New perspectives into the chemical characterization of Sida acuta Burm. f. extracts with respect to its anti-cancer, antioxidant and enzyme inhibitory effects. Process Biochemistry 2021; 105, 91-101.

SH Mah, SS Teh and GCL Ee. Anti-inflammatory, anti-cholinergic and cytotoxic effects of Sida rhombifolia. Pharmaceutical Biology 2017; 55(1), 920-928.

M Ganesh and M Mohankumar. Extraction and identification of bioactive components in Sida cordata (Burm.f.) using gas chromatography-mass spectrometry. Journal of Food Science and Technology 2017; 54(10), 3082-3091.

V Simon, DD Ho and QA Karim. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 2006; 368(9534), 489-504.

YV Heuvel, S Schatz, JF Rosengarten and J Stitz. Infectious RNA: Human immunodeficiency virus (HIV) biology, therapeutic intervention, and the quest for a vaccine. Toxins 2022; 14(2), 138.

S Suryono and N Nasronudin. Clinical description and diagnosis of HIV/AIDS. Indonesian Journal of Tropical and Infectious Disease 2015; 5(1), 23.

H Chen, R Zhang, R Luo, L Yang, R Wang, X Hao and Y Zheng. Anti-HIV activities and mechanism of 12-O-tricosanoylphorbol-20-acetate, a novel phorbol ester from Ostodes katharinae. Molecules 2017; 22(9), 1498.

J Zhao, C Liu, W Qi, M Han, Y Han, MA Wainberg and J Yue. Eurifoloids A-R, structurally diverse diterpenoids from euphorbia neriifolia. Journal of Natural Products 2014; 77(10), 2224-2233.

T Samji. Influenza A: Understanding the viral life cycle. Yale Journal of Biology and Medicine 2009; 82(4), 153-159.

Y Kang, Y Shi and S Xu. Arbidol: The current demand, strategies, and antiviral mechanisms. Immunity, Inflammation and Disease 2023; 11(8), e984.

L Zhao, K Xiang, R Liu, Z Xie, S Zhang and S Dai. Anti-inflammatory and anti-viral labdane diterpenoids from the fruits of Forsythia suspensa. Bioorganic Chemistry 2020; 96, 103651.

TKQ Ha, TT Dao, NH Nguyen, J Kim, E Kim, TO Cho and WK Oh. Antiviral phenolics from the leaves of Cleistocalyx operculatus. Fitoterapia 2016; 110, 135-141.

I Zanella, D Zizioli, F Castelli and E Quiros-Roldan. Correction to: Zanella et al. tenofovir, another inexpensive, well known and widely available old drug repurposed for sars-cov-2 infection. pharmaceuticals 2021, 14, 454. Pharmaceuticals 2021; 14(8), 454.

P V’kovski, A Kratzel, S Steiner, H Stalder and V Thiel. Coronavirus biology and replication: Implications for SARS-CoV-2. Nature Reviews Microbiology 2021; 19(3), 155-170.

Z Zuo, T Wu, L Pan, C Zuo, Y Hu, X Luo, L Jiang, Z Xia, X Xiao, J Liu, M Ye and M Deng. Modalities and mechanisms of treatment for coronavirus disease 2019. Frontiers in Pharmacology 2021; 11, 583914.

JH Zhao, YW Wang, J Yang, Z Tong, J Wu, Y Wang, Q Wang, Q Li, Y Yu, X Leng, L Chang, X Xue, S Sun, H Li, N Ding, J Duan, N Li and Z Shi. Natural products as potential lead compounds to develop new antiviral drugs over the past decade. European Journal of Medicinal Chemistry 2023; 260, 115726.

YB Ryu, HJ Jeong, JH Kim, YM Kim, J Park, D kim, TTH Nguyen, S Park, JS Chang, KH Park, M Rho and WS Lee. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition. Bioorganic and Medicinal Chemistry 2010; 18(22), 7940-7947.

P Kanjanasirirat, A Suksatu, S Manopwisedjaroen, B Munyoo, P Tuchinda, K Jearawuttanakul, S Seemakhan, S Charoensutthivarakul, P Wongtrakoongate, N Rangkasenee, S Pitiporn, N Waranuch, N Chabang, P Khemawoot, K Sa-ngiamsuntorn, Y Pewkliang, P Thongsri, S Chutipongtanate, S Hongeng, ..., A Thitithanyanont. High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component panduratin A as anti-SARS-CoV-2 agents. Scientific Reports 2020; 10(1), 19963.

R Whitley and J Baines. Clinical management of herpes simplex virus infections: Past, present, and future. F1000Research 2018; 7, 1726.

S Zhu and A Viejo-Borbolla. Pathogenesis and virulence of herpes simplex virus. Virulence 2021; 12(1), 2670-2702.

LVD Sand, M Bormann, Y Schmitz, CS Heilingloh, O Witzke and A Krawczyk. Antiviral active compounds derived from natural sources against herpes simplex viruses. Viruses 2021; 13(7), 1386.

M Rittà, A Marengo, A Civra, D lembo, C Cagliero, K Kant, UM Lal, P Rubolo, M Ghosh and M Donalisio. Antiviral activity of a arisaema tortuosum leaf extract and some of its constituents against herpes simplex virus type 2. Planta Medica 2020; 86(4), 267-275.

M Donalisio, V Cagno, A Civra, D Gibellini, G Musumeci, M Ritta, M Ghosh, D Lembo. The traditional use of Vachellia nilotica for sexually transmitted diseases is substantiated by the antiviral activity of its bark extract against sexually transmitted viruses. Journal of Ethnopharmacology 2018; 213, 403-408.

DZ Rechenchoski, KF Agostinho, LC Faccin-Galhardi, AASG lonni, JVHD Silva, FGD Andrade, NMPS Ricaardo, C Nozawa and REC Lnhares. Mangiferin: A promising natural xanthone from Mangifera indica for the control of acyclovir - resistant herpes simplex virus 1 infection. Bioorganic and Medicinal Chemistry 2020; 28(4), 115304.

U Saeed, Y Waheed and M Ashraf. Hepatitis B and hepatitis C viruses: A review of viral genomes, viral induced host immune responses, genotypic distributions and worldwide epidemiology. Asian Pacific Journal of Tropical Disease 2014; 4(2), 88-96.

World Health Organization. Global Hepatitis Report 2024. World Health Organization, Geneva, Switzerland, 2024.

A Petruzziello, S Marigliano, G Loquercio, A Cozzolino and C Cacciapuoti. Global epidemiology of hepatitis C virus infection : An up-date of the distribution and circulation of hepatitis C virus genotypes. World Journal of Gastroenterology 2016; 22(34), 7824-7840.

PH Almeida, CEL Matielo, LA Curvelo, RA Rocco, G Felga, BD Guardia and YL Boteon. Update on the management and treatment of viral hepatitis. World Journal of Gastroenterology 2021; 27(23), 3249-3261.

K Dyrka, M Miedziaszczyk, E Szalek and K Lacka. Drugs used in viral diseases - their mechanism of action, selected adverse effects and safety during pregnancy and lactation. Postepy Higieny i Medycyny Doswiadczalnej 2019; 73, 491-507.

KAE Sayed. Natural products as antiviral agents. Studies in Natural Products Chemistry 2007; 24, 473-572.

D Susiloningrum, AA Permanasari, M Adianti, L Tumewu, TS Wahyuni, M Tanjung, A Widyawaruyanti and AF Hafid. The alkaloid fraction from melicope latifolia leaves inhibits hepatitis C Virus. Pharmacognosy Journal 2020; 12(3), 535-540.

TS Wahyuni, A Widyawaruyanti, MI Lusida, A Fuad, Soetjipto, H Fuchino, N Kawahara, Y Hayashi, C Aoki and H Hotta. Inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from Ruta angustifolia leaves. Fitoterapia 2014; 99, 276-283.

H Xu, Y Ma, X Huang, C Geng, H Wang, Y Zhao, T Yang, X Chen, C Yang, X Zhang and J Chen. Bioactivity-guided isolation of anti-hepatitis B virus active sesquiterpenoids from the traditional Chinese medicine: Rhizomes of cyperus rotundus. Journal of Ethnopharmacology 2015; 171, 131-140.

S Tamura, M Kaneko, A Shiomi, G Yang, T Yamaura and N Murakami. Unprecedented NES non-antagonistic inhibitor for nuclear export of Rev from Sida cordifolia. Bioorganic and Medicinal Chemistry Letters 2010; 20(6), 1837-1839.

BC Kamdoum, I Simo, SCN Wouamba, BMT Tali, B Ngameni, GW Fotso, P Ammbassa, FB Fabrice, BN Lenta, N Sewald and BT Ngadjui. Bathelemy chemical constituents of two cameroonian medicinal plants: Sida rhombifolia L. and Sida acuta Burm. f. (Malvaceae) and their antiplasmodial activity. Natural Product Research 2022; 36, 5311-5318.

M Thondawada, S Mulukutla, KRS Raju, SP Dhanabal and AD Wadhwani. In vitro and In vivo evaluation of Sida Acuta burm.f. (Malvaceae) for its anti-oxidant and anti-cancer activity. Der PharmaChemica 2016; 8(19), 396-402.

TJ Ramesh, HNR Babu, N Rajeshwari, KY Prathibha and E keshmma. Determination of antifungal potential of Sida acuta. Journal of Medicinal Plants Studies 2022; 10(5), 21-25.

JP Essien, BS Antia and GA Ebong. Phytochemistry, antibacterial and anticoagulase activities of Sida acuta against clinical isolates of Staphylococcus aureus. Journal of Applied and Natural Science 2009; 1(1), 1-7.

K Anani, JB Hudson, CD Souza, K Akpagana, GHN Tower, JT Arnason and M Gbeassor. Investigation of medicinal plants of togo for antiviral and antimicrobial activities. Pharmaceutical Biology 2000; 38(1), 40-45.

M Govindarajan. Larvicidal and repellent activities of Sida acuta Burm. F. (Family: Malvaceae) against three important vector mosquitoes. Asian Pacific Journal of Tropical Medicine 2010; 3(9), 691-695.

G Indrayanto, GS Putra and F Suhud. Validation of in-vitro bioassay methods: Application in herbal drug research. Profiles of Drug Substances, Excipients and Related Methodology 2021; 46, 273-307.

JB Hudson, K Anani, MK Lee, CD Souza, JT Arnason and M Gbeassor. Further investigations on the antiviral activities of medicinal plants of togo. Pharmaceutical Biology 200; 38(1), 46-50.

Center for Drug Evaluation and Research. Guidance for industry antiviral product development - conducting and submitting virology studies to the agency. Center for Drug Evaluation and Research, Maryland, 2006.

Downloads

Published

2025-02-10